triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN Tablets USP 50 Supply Disruption — Teva Pharmaceuticals USA (Mod
triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN Tablets USP 50 Supply Disruption — Teva Pharmaceuticals USA (Mod is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN Tablets USP 50; Manufacturer: Teva
| Drug name | triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN Tablets USP 50 |
|---|---|
| Manufacturer | Teva Pharmaceuticals USA |
| Recall/Disruption reason | Failed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obt |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1499-2014 |
| Initiation date | 20140401 |
| Quantity affected | 89,215 blister pack |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →